Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2025
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagsonpal Pharmaceuticals Limited has officially informed the stock exchange about its upcoming Annual General Meeting (AGM) scheduled for September 24, 2025. This is a standard regulatory filing required of all listed companies to notify shareholders and the exchange about the AGM. The AGM is typically where shareholders vote on key matters such as appointment of directors, approval of financial statements, and declaration of dividends. No specific agenda items or financial proposals have been disclosed in this particular filing, though these would be detailed in the actual notice sent to shareholders.
This is a routine compliance filing with no direct impact on stock price or business operations. Shareholders should note the AGM date for attending or voting, and watch for the detailed notice which will outline agenda items including any dividend or fundraising proposals.